Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: Relationship between urinary biomarkers and oral leukoplakia

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 7, 1996, Pages 521-525

  Kresty, Laura A ^a   Carmella, Steven G ^b   Borukhova, Anna ^b   Akerkar, Shobha A ^b   Gopalakrishnan, Rajaram ^a   Harris, Randall E ^a   Stoner, Gary D ^a   Hecht, Stephen S ^b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BIOLOGICAL MARKER; COTININE; CREATININE; NITROSAMINE;

ARTICLE; CARCINOGENICITY; HUMAN; LEUKOPLAKIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING AND SMOKING RELATED PHENOMENA; URINE LEVEL;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOGENS; CONFIDENCE INTERVALS; HUMANS; INCIDENCE; LEUKOPLAKIA, ORAL; MALE; NITROSAMINES; ODDS RATIO; PLANTS, TOXIC; SENSITIVITY AND SPECIFICITY; TOBACCO, SMOKELESS;

EID: 0030037219     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Winn, D. M. Surveillance of and knowledge about cancer associated with smokeless tobacco use. In: Smokeless Tobacco or Health, Smoking and Tobacco Monograph 2, pp. 11-18. Washington, DC: U.S. Department of Health and Human Services, 1992.
2. Office of Smoking and Health, U.S. Department of Health and Human Services. Use of smokeless tobacco among adults: United States, 1991. Morb. Mortal. Wkly. Rep., 42: 263-266, 1993.
3. IARC. Tobacco habits other than smoking: betel quid and areca nut chewing; and some related nitrosamines. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, pp. 43-49. Lyon, France: IARC, 1985.
4. IARC. Tobacco habits other than smoking: betel quid and areca nut chewing; and some related nitrosamines. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, p. 116. Lyon, France: IARC, 1985.
5. U.S. Department of Health and Human Services. The Health Consequences of Using Smokeless Tobacco: a Report of the Advisory Committee to the Surgeon General, p. 55. Bethesda, MD: U.S. Public Health Service, 1986.
6. U.S. Department of Health and Human Services. Health Implications of Smokeless Tobacco Use: NIH Consensus Development Conference, Vol. 6. Washington, DC: Office of Medical Applications of Research, 1986.
7. U.S. Department of Health and Human Services. The Health Consequences of Using Smokeless Tobacco: a Report of the Advisory Committee to the Surgeon General, pp. 99-135., 1986.
8. IARC. Tobacco habits other than smoking: betel quid and areca nut chewing; and some related nitrosamines. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, pp. 89-91. Lyon, France: IARC, 1985.
9. Ernster, V. L., Grady, D. G., Greene, J. C., Walsh, M., Robertson, P., Daniels, T. E., Benowitz, N., Siegel, D., Gerbert, B., and Hauck, W. W. Smokeless tobacco use and health effects among baseball players. J. Am. Med. Assoc., 264: 218-224, 1990.
10. Hoffmann, D., and Hecht, S. S. Smokeless tobacco and cancer. ISI Atlas of Science: Pharmacology, 2: 46-52, 1988.
11. Hoffmann, D., Brunnemann, K. D., Prokopezyk, B., and Djordjevic, M. V. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health, 41: 1-52, 1994.
12. Hecht, S. S., and Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (Lond.), 9: 875-884, 1988.
13. Djordjevic, M. V., Brunnemann, K. D., and Hoffmann, D. Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco. Carcinogenesis (Lond.), 10: 1725-1731, 1989.
14. Prokopczyk, B., Wu, M., Cox, J. E., Amin, S., Desai, D., Idris, A. M., and Hoffmann, D. Improved methodology for the quantitative assessment of tobacco-specific N-nitrosamines in tobacco by supercritical fluid extraction. J. Agric. Food Chem., 43: 916-922, 1995.
15. Hecht, S. S., Rivenson, A., Braley, J., DiBello, J., Adams, J. D., and Hoffmann, D. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res., 46: 4162-4166, 1986.
16. Prokopezyk, B., Rivenson, A., and Hoffmann, D. A study of betel quid Carcinogenesis IX: comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett., 60: 153-157, 1991.
17. Hecht, S. S., and Hoffmann, D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv., 8: 273-294, 1989.
18. Magee, P. N. The experimental basis for the role of nitroso compounds in human cancer. Cancer Surv., 8: 207-239, 1989.
19. Preston-Martin, S., and Correa, P. Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv., 8: 459-473, 1989.
20. Hoffmann, D., and Adams, J. D. Carcinogenic tobacco-specific N-nitrosamines in snuff and saliva of snuff dippers. Cancer Res., 41: 4305-4308, 1981.
21. Palladino, G., Adams, J. D., Brunnemann, K. D., Haley, N. J., and Hoffmann, D. Snuff-dipping in college students: a clinical profile. Mil. Med., 151: 342-346, 1986.
22. Brunnemann, K. D., Hornby, A. P., and Stitch, H. F. Tobacco-specific nitrosamines in the saliva of Inuit snuff dippers in the Northwest Territories of Canada. Cancer Lett., 37: 7-16, 1987.
23. Österdahl, B-G., and Slorach, S. Tobacco-specific N-nitrosamines in the saliva of habitual male snuff dippers. Food Addit. Contain., 5: 581-586, 1988.
24. Stich, H. F., Brunnemann, K. D., Mathew, B., Sankaranarayanan, R., and Nair, M. K. Chemopreventive trials with vitamin A and β-carotene: some unresolved issues. Prev. Med., 18: 732-739, 1989.
25. Stich, H. F., Parida, B. B., and Brunnemann, K. D. Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of "reverse" smokers, Khaini tobacco chewer and Gudakhu user. Int. J. Cancer, 50: 172-176, 1992.
26. Bhide, S. V., Nair, U. J., Nair, J., Spiegelhalder, B., and Preussmann, R. N-Nitrosamines in the saliva of tobacco chewers and masheri users. Food Chem. Toxicol., 24: 293-297, 1986.
27. Nair, J., Ohshima, H., Friesen, M., Croisy, A., Bhide, S. V., and Bartsch, H. Tobacco-specific and betel nut-specific W-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis (Lond.). 6: 295-303, 1985.
28. Idris, A. M., Nair, J., Friesen, M., Ohshima, H., Brauet, I., Faustman, E. M., and Bartsch, H. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis (Lond.), 13: 1001-1005, 1992.
29. Carmella, S. G., Kagan, S. S., Kagan, M., Foiles, P. G., Palladino, G., Quart, A. M., Quart, E., and Hecht, S. S. Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res., 50: 5438-5445, 1990.
30. Falter, B., Kutzer, C., and Richter, E. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Investis., 72: 364-371, 1994.
31. Murphy, S. E., Carmella, S. G., Idris, A. M., and Hoffmann, D. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol., Biomarkers & Prev., 3: 423-428, 1994.
32. Carmella, S. G., Akerkar, S., and Hecht, S. S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res., 53: 721-724, 1993.
33. Carmella, S. G., Akerkar, S., Richie, J. P., Jr., and Hecht, S.S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol., Biomarkers & Prev., 4: 635-642, 1995.
34. Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S., and Hecht, S. S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res., 48: 6912-6917, 1988.
35. Castonguay, A., Lin, D., Stoner, G. D., Radok, P., Furuya, K., Hecht, S. S., Schut, H. A. J., and Klaunig, J. E. Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res., 43: 1223-1229, 1983.
36. Morse, M. A., Eklind, K. I., Toussaint, M., Amin, S. G., and Chung, F-L. Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis (Lond.), 11: 1819-1823, 1990.
37. Hecht, S. S., Trushin, N., Reid-Quinn, C. A., Burak, E. S., Jones, A. B., Southers, J. L., Gombar. C. T., Carmella, S. G., Anderson, L. M., and Rice, J. M. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis (Lond.), 14: 229-236, 1993.
38. Haley, N. J., Axelrad, C. M., and Tilton, K. A. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am. J. Public Health, 73: 1204-1207, 1984.
39. Mantel, N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J. Am. Stat. Assoc., 58: 690-700, 1963.
40. Benowitz, N. L., Jacob, P., III, and Yu, L. Daily use of smokeless tobacco: systemic effects. Ann. Intern. Med., 111: 112-116, 1989.
41. Benowitz, N. L. Pharmacology of smokeless tobacco use: nicotine addiction and nicotine-related health consequences. In: Smokeless Tobacco or Health, Smoking and Tobacco Control Monograph 2, pp. 219-238. Washington, DC: U.S. Department of Health and Human Services, 1992.
42. Grady, D., Greene, J., Daniels, T. E., Ernster, V. L., Robertson, P. B., Hauck, W., Greenspan, D., Greenspan, J., and Silverman, S., Jr. Oral mucosal lesions found in smokeless tobacco users. J. Am. Dent. Assoc., 121: 117-123, 1990.
43. Andersson, G., Björnberg, G., and Curvall, M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J. Oral Pathol. & Med., 23: 161-167, 1994.
44. Miners, J. O., and Mackenzie, P. I. Drug glucuronidation in humans. Pharmacol. & Ther., 51: 347-369, 1991.
45. LaVoie, E. J., Tucciarone, P., Kagan, M., Adams, J. D., and Hoffmann, D. Analysis of steam distillates and aqueous extracts of smokeless tobacco. J. Agric. Food Chem., 37: 154-157, 1989.
46. Diamond, G. L., Anders, M. W., Tremaine, L. M., and Quebbemann, A. J. Salicylate enhancement of renal glucuronide conjugation and tubular excretory transfer of phenols. Drug Metab. Dispos., 10: 573-578, 1982